Skip to main content
. Author manuscript; available in PMC: 2017 May 30.
Published in final edited form as: Stroke. 2014 Aug 21;45(10):2967–2973. doi: 10.1161/STROKEAHA.114.005982

Table 1. Characteristics of individuals starting a drug or increasing the dose for each drug class.

CCB= calcium channel blocker alone; RASi=renin-angiotensin system inhibitor, with or without a diuretic; Diuretic=diuretic alone. Frequencies (%) are given, compared by chi-squared tests, means by ANOVA. AF = atrial fibrillation; BMI = body mass index; TSH = thyroid stimulating hormone; CCB = calcium channel blocker; RASi = renin-angiotensin system inhibitor; D = diuretic.

CCB (n=131) RASi (n=55) Diuretic (n=47) RASi +D (n=50) p-value
Male 55 (42) 27 (49) 21 (45) 21 (42) 0.83
Hypertension 84 (64) 31 (56) 27 (57) 28 (56) 0.64
Family History 31 (24) 18 (33) 9 (19) 14 (28) 0.41
Hyperlipidaemia 56 (43) 21 (38) 17 (36) 20 (40) 0.86
Diabetes 23 (18) 9 (16) 3 (6) 9 (18) 0.30
Heart Failure 11 (8) 5 (9) 2 (4) 2 (4) 0.59
AF 18 (14) 2 (4) 8 (17) 6 (12) 0.16
Smoker 19 (15) 6 (11) 10 (21) 7 (14) 0.52
Stroke vs TIA 76 (58) 32 (58) 24 (51) 26 (52) 0.75
Myocardial Infarction 3 (2) 1 (2) 4 (9) 3 (6) 0.19
Age 69.8 69.7 68.6 69.1 0.96
BMI 27.4 27.8 28.3 27.2 0.70
Creatinine 92.2 93.3 83.3 94.2 0.12
Cholesterol 5.1 5.4 5.3 5.1 0.59
TSH 2.3 2.2 2.1 2.2 0.96